Showing 2101-2110 of 4166 results for "".
- Keeping Your Vision Safe During a Natural Disasterhttps://modernod.com/news/keeping-your-vision-safe-during-a-natural-disaster/2477424/Parkhurst Nuvision in San Antonio, Texas, posted the following advisory to its patients, which providing tips for managing vision needs in an emergency. When faced with the forces of nature – in particular flooding and contaminated waters – people who rely on contact lenses to see well fa
- Mojo Vision Developing Smart Contact Lenshttps://modernod.com/news/mojo-vision-developing-smart-contact-lens/2477237/Mojo Vision announced it is building what it calls the “world’s first true smart contact lens,” called the Mojo Lens. Mojo Lens is a contact lens with a built-in display that gives people useful and timely information without forcing them to look down at a screen or losing focus on th
- Prism Vision Group Announces Launch of New Brandhttps://modernod.com/news/prism-vision-group-announces-launch-of-new-brand/2476726/Prism Vision Group, an ophthalmology administrative services care provider organization, was officially launched. The new entity is led by Steven Madreperla, MD, PhD, a practicing ophthalmologist and one of the founding partners of NJRetina, a specialty retina practice with roots that reac
- Alcon Launches Advancements to the Centurion Vision System at ASCRShttps://modernod.com/news/alcon-launches-advancements-to-the-centurion-vision-system-at-ascrs/2476556/Alcon introduced new phaco technology that is part of the Centurion Vision System, including the Active Sentry Handpiece and Intrepid Hybrid Tip, at the ASCRS annual meeting. These new products, which are designed to improve safety, consistency and control during cataract surgery,
- SECO 2019 Puts Spotlight On Vision Industry Trendshttps://modernod.com/news/seco-2019-puts-spotlight-on-vision-industry-trends/2479643/SECO 2019 will lead the conversation on the latest vision industry trends when SECO 2019 takes place February 20-24, 2019 in New Orleans. From the latest technological innovations in eye and healthcare to up-and-coming eyewear products, SECO 2019 is where the optometric community of professional
- American Vision Partners Acquires Miles Eye Centerhttps://modernod.com/news/american-vision-partners-acquires-miles-eye-center/2480084/Private Equity-backed American Vision Partners announced a partnership between one of its affiliates, Barnet Dulaney Perkins Eye Center, and Miles Eye Center. Under the name of Barnet Dulaney Perkins Eye Center, patients at Mi
- Cincinnati Eye Institute Launches CEI Vision Partnershttps://modernod.com/news/cincinnati-eye-institute-launches-cei-vision-partners/2480134/Cincinnati Eye Institute (CEI) announced the launch of CEI Vision Partners (CEIVP), a new management services organization made possible with the support of Revelstoke Capital Partners, a Denver-based private equity firm. “For more than 70 years, CEI has been growing as a world-class
- SynergEyes and Brien Holden Vision Institute Join Forces for Specialty Contact Lens Developmenthttps://modernod.com/news/synergeyes-and-brien-holden-vision-institute-join-forces-for-specialty-contact-lens-development/2480098/SynergEyes announced a new partnership with the Brien Holden Vision Institute, a translational vision correction center that delivers advanced, customized vision correction for myopes and presbyopes. The exclusive worldwide licensing agreement will enable the manufacturing of design technologies
- Vision Expo Organizers Announce New Educational Planning Committee and OptiCon Advisory Board Members for Upcoming Meetingshttps://modernod.com/news/vision-expo-organizers-announce-new-educational-planning-committee-and-opticon-advisory-board-members-for-upcoming-meetings/2480886/The Vision Council and RX—co-organizers of Vision Expo—announced the new Educational Planning Committee and new members of the OptiCon Advisory Board that will oversee the education program for Vision Expo West 2022 and Vision Expo East 2023.
- Oculis Announces Positive Data From Two Proof-of-Concept Phase 2 Trials With OCS-02 in Dry Eye Disease and Acute Anterior Uveitishttps://modernod.com/news/oculis-announces-positive-data-from-two-proof-of-concept-phase-2-trials-with-ocs-02-in-dry-eye-disease-and-acute-anterior-uveitis/2479192/Oculis announced positive data from two clinical proof of concept phase 2 trials with OCS-02, its novel, topical anti-TNF alpha antibody fragment candidate, in dry eye disease (DED) and acute anterior uveitis (AAU). The data were presented for the first time at ARVO 2021, the annual meeting of th